Share on StockTwits

Becton, Dickinson and (NYSE:BDX) has been given an “AA-” credit rating by Morningstar. The agency’s “AA-” rating indicates that the company is a very-low default risk. They also issued a negative credit outlook for the company and gave their stock a four star rating.

BDX has been the subject of a number of other recent research reports. Analysts at JPMorgan Chase & Co. reiterated an “underweight” rating on shares of Becton, Dickinson and in a research note on Friday, August 1st. They now have a $115.00 price target on the stock, up previously from $111.00. Separately, analysts at RBC Capital raised their price target on shares of Becton, Dickinson and from $113.00 to $116.00 in a research note on Friday, August 1st. Finally, analysts at Leerink Swann raised their price target on shares of Becton, Dickinson and from $117.00 to $120.00 in a research note on Friday, August 1st. Two equities research analysts have rated the stock with a sell rating, four have given a hold rating and six have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $112.90.

Becton, Dickinson and (NYSE:BDX) opened at 116.85 on Wednesday. Becton, Dickinson and has a 1-year low of $97.15 and a 1-year high of $120.66. The stock’s 50-day moving average is $117.4 and its 200-day moving average is $116.5. The company has a market cap of $22.416 billion and a price-to-earnings ratio of 23.79.

Becton, Dickinson and (NYSE:BDX) last released its earnings data on Thursday, July 31st. The company reported $1.65 EPS for the quarter, missing the Thomson Reuters consensus estimate of $1.67 by $0.02. The company had revenue of $2.16 billion for the quarter, compared to the consensus estimate of $2.14 billion. During the same quarter in the prior year, the company posted $1.58 earnings per share. The company’s quarterly revenue was up 5.1% on a year-over-year basis. On average, analysts predict that Becton, Dickinson and will post $6.25 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which is scheduled for Tuesday, September 30th. Stockholders of record on Tuesday, September 9th will be given a dividend of $0.545 per share. This represents a $2.18 dividend on an annualized basis and a yield of 1.87%. The ex-dividend date of this dividend is Friday, September 5th.

Becton Dickinson and Co is a global medical technology company engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.

To view more credit ratings from Morningstar, visit

Receive News & Ratings for Becton Dickinson and Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Co and related companies with Analyst Ratings Network's FREE daily email newsletter.